Ben Goldacre
Ben Goldacre
Підтверджена електронна адреса в - Домашня сторінка
Bad Science
B Goldacre
McClelland & Stewart, 2010
Bad pharma: how drug companies mislead doctors and harm patients
B Goldacre
Macmillan, 2014
Functional heterogeneity of left inferior frontal cortex as revealed by fMRI
E Paulesu, B Goldacre, P Scifo, SF Cappa, MC Gilardi, I Castiglioni, ...
Neuroreport 8 (8), 2011-2016, 1997
Building evidence into education
B Goldacre
Department for Education, 2013
What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid …
JA Finegold, CH Manisty, B Goldacre, AJ Barron, DP Francis
European journal of preventive cardiology 21 (4), 464-474, 2014
Test, Learn, Adapt: Developing Public Policy with Randomised Controlled Trials| Cabinet Office
L Haynes, B Goldacre, D Torgerson
Cabinet Office Behavioural Insights Team, 2012
Pragmatic randomised trials using routine electronic health records: putting them to the test
TP van Staa, B Goldacre, M Gulliford, J Cassell, M Pirmohamed, A Taweel, ...
Bmj 344, e55, 2012
The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials.
TP van Staa, L Dyson, G McCann, S Padmanabhan, R Belatri, B Goldacre, ...
Health technology assessment (Winchester, England) 18 (43), 1-146, 2014
Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data
A Matthews, E Herrett, A Gasparrini, T Van Staa, B Goldacre, L Smeeth, ...
bmj 353, i3283, 2016
Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis
D Veale, S Miles, N Smallcombe, H Ghezai, B Goldacre, J Hodsoll
BMC psychiatry 14 (1), 317, 2014
Bad pharma: how medicine is broken and how we can fix it
B Goldacre
Macmillan, 2014
Bad pharma: how medicine is broken, and how we can fix it
B Goldacre
HarperCollins UK, 2012
Who owns the data? Open data for healthcare
P Kostkova, H Brewer, S de Lusignan, E Fottrell, B Goldacre, G Hart, ...
Frontiers in public health 4, 7, 2016
Why clinical trial outcomes fail to translate into benefits for patients
C Heneghan, B Goldacre, KR Mahtani
Trials 18 (1), 122, 2017
Benefits and risks of homoeopathy
B Goldacre
The Lancet 370 (9600), 1672-1673, 2007
Evidence based medicine manifesto for better healthcare
C Heneghan, KR Mahtani, B Goldacre, F Godlee, H Macdonald, D Jarvies
Bmj 357, j2973, 2017
The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?
TP van Staa, L Smeeth, ESW Ng, B Goldacre, M Gulliford
Heart 99 (21), 1597-1602, 2013
Survival analysis of Irish amyotrophic lateral sclerosis patients diagnosed from 1995–2010
J Rooney, S Byrne, M Heverin, B Corr, M Elamin, A Staines, B Goldacre, ...
PloS one 8 (9), e74733, 2013
The quality of the evidence for dietary advice given in UK national newspapers
BEJ Cooper, WE Lee, BM Goldacre, TAB Sanders
Public Understanding of Science 21 (6), 664-673, 2012
How to get all trials reported: audit, better data, and individual accountability
B Goldacre
PLoS medicine 12 (4), e1001821, 2015
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20